Answer
Headache, injection site reaction, and nausea were the most commonly reported adverse reactions after intravenous SonoVue (sulfur hexafluoride) in adult clinical trials.
Sources for this answer
- SonoVue 8 microlitres/ml, powder and solvent for dispersion for injectionBracco UK Limited · emc · SmPC §4.8 Undesirable effects · Version 16Document updated
Sources checked